Cephalon, And Insys: A Case Study

Drug companies like Perdue, Cephalon, and Insys are focused more on marketing than patient care. It is alarming that these companies would rather push sales however possible and risk consequences like being sued for hundreds of millions of dollars. Something that really stood out to me was when the ex Insys employee spoke about what she and the company did by saying “uh huh” to when they were asked if a patient had cancer in order to not only push the sales of their drug(s) but to get insurance companies to pay for it (Oliver). In addition, if money is more important than the well being of others for these companies, how many more are just like them? Well it turns out that there are many more companies that are doing the same things that

In Erie County, there was a civil lawsuit filed against eleven pharma manufacturing companies for worsening the rampant opioid situation. "These drug makers and their enablers in the medical community were aware of the significant dangers posed by opioid prescription medications, yet that did not stop them from continuing to push opioids, and get even more people hooked on them," Poloncarz said. "In order to realize blockbuster profits, the defendants created a false perception of the safety and efficacy of opioids that would encourage the use of opioids for longer periods of time and to treat a wide-range of problems. They did this through a coordinated, sophisticated and highly deceptive marketing campaign…” (Niagara-Wheatfield Tribune). Furthermore, it seems as if the consequences are not of concern to these pharma companies as they are continuing to do what they have to in order to achieve sales. I feel that the situation will increasingly worsen as the people are being misinformed and manipulated for profit. Consequently, these companies will keep doing these deceptive marketing schemes as long as there is money to be made. Now I am not suggesting stopping